http://www.fpnotebook.com/
Major Histocompatibility Complex Antigens
Aka: Major Histocompatibility Complex Antigens, Human Leukocyte Antigen B27, HLA-B27
- Indications
- Extremely limited use in clinical practice
- May be indicated if spondylitis strongly suspected
- Methods of Testing
- Antibody binding to patient's cells
- Mixed Lymphocyte responses against specific targets
- Hybridization to DNA probes
- Efficacy
- Test Sensitivity for Spondyloarthropathy: 84%
- Test Specificity for Spondyloarthropathy: 96%
- Conditions associated with HLA-B27 (with Incidence)
- Ankylosing Spondylitis: 95%
- Reiter's Syndrome: 80%
- Spondylitis with Psoriasis: 70%
- Spondylitis with Inflammatory Bowel Disease: 50%
- Incidence in general population without disease: 6-8%
- References
- Gregersen in Ruddy (2001) Kelly's Rheumatology, p. 101
- Lane (2002) Am Fam Physician 65(6):1073-80